MetLife Investment Management’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Buy
49,203
+4,930
+11% +$66K ﹤0.01% 1764
2026
Q1
$556K Buy
44,273
+2,020
+5% +$26.3K ﹤0.01% 1696
2025
Q4
$525K Sell
42,253
-6,181
-13% -$78.5K ﹤0.01% 1777
2025
Q3
$640K Hold
48,434
– – ﹤0.01% 1690
2025
Q2
$672K Hold
48,434
– – ﹤0.01% 1534
2025
Q1
$621K Sell
48,434
-797
-2% -$11.2K ﹤0.01% 1607
2024
Q4
$689K Buy
49,231
+2,694
+6% +$40.4K ﹤0.01% 1617
2024
Q3
$737K Hold
46,537
– – ﹤0.01% 1569
2024
Q2
$596K Buy
46,537
+13,467
+41% +$171K ﹤0.01% 1621
2024
Q1
$457K Sell
33,070
-7,679
-19% -$107K ﹤0.01% 1724
2023
Q4
$610K Hold
40,749
– – ﹤0.01% 1573
2023
Q3
$667K Hold
40,749
– – 0.01% 1458
2023
Q2
$705K Hold
40,749
– – 0.01% 1473
2023
Q1
$689K Buy
40,749
+2,220
+6% +$42.5K 0.01% 1445
2022
Q4
$636K Sell
38,529
-3,197
-8% -$59.6K ﹤0.01% 1490
2022
Q3
$653K Buy
41,726
+1,404
+3% +$36.6K 0.01% 1444
2022
Q2
$1.07M Sell
40,322
-1,264
-3% -$37.5K 0.01% 1173
2022
Q1
$1.5M Buy
41,586
+15,932
+62% +$634K 0.01% 1114
2021
Q4
$1.16M Sell
25,654
-1,725
-6% -$81.6K 0.01% 1068
2021
Q3
$1.22M Hold
27,379
– – 0.01% 1037
2021
Q2
$1.24M Buy
27,379
+5,633
+26% +$234K 0.01% 1061
2021
Q1
$829K Sell
21,746
-3,658
-14% -$125K 0.01% 1251
2020
Q4
$781K Hold
25,404
– – 0.01% 1244
2020
Q3
$625K Sell
25,404
-3,236
-11% -$86.2K 0.01% 1254
2020
Q2
$826K Buy
+28,640
New +$736K 0.01% 1107
2019
Q2
– Sell
-255
Closed -$14.6K – 2460
2019
Q1
$14.6K Buy
255
+170
+200% +$9.56K ﹤0.01% 2470
2018
Q4
$4.53K Hold
85
– – ﹤0.01% 2470
2018
Q3
$4.64K Buy
+85
New +$4.78K ﹤0.01% 2532

Other funds holding CIM

MetLife Investment Management's CIM Position: Q2 2026 in Review

MetLife Investment Management increased its Chimera Investment (CIM) stake by 11% in Q2 2026, buying an estimated $66K and bringing the position to 49,203 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

MetLife Investment Management first reported a position in CIM in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.5M in Q1 2022. 197 funds tracked by Wall St. Rank hold CIM as of Q2 2026.

  • MetLife Investment Management held 49,203 shares of Chimera Investment worth $656K as of Q2 2026.
  • MetLife Investment Management bought 4,930 Chimera Investment shares in Q2 2026, an estimated $66K.
  • Chimera Investment made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1764 holding.
  • MetLife Investment Management first reported a position in Chimera Investment in Q3 2018 and has held it in 28 quarters since.
  • MetLife Investment Management's Chimera Investment position peaked at $1.5M in Q1 2022.
  • 197 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.